HEALTHSMART supplier risk profile Q1 2026: China-heavy import footprint, 54 suppliers, 96 shipments, C-grade risk.
HEALTHSMART imported 96 shipments across 54 suppliers in Q1 2026, with sourcing heavily concentrated in China (91% of shipments). The company's top supplier, SUZHOU PIPI MEDICAL LT, accounted for 14 shipments alone. Trade originated from three countries: mainland China, Hong Kong, and Taiwan. No HS codes were classified in the dataset, limiting product-category visibility.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
HEALTHSMART registered zero sanctions watchlist matches in Q1 2026. No suppliers in the network showed Uyghur Forced Labor Prevention Act (UFLPA) exposure. The importer's overall supplier-risk score is 69 (grade C), reflecting moderate operational and supply-chain risk factors.
54 distinct tier-1 suppliers in Q1 2026
| SUZHOU PIPI MEDICAL LT | China | 14 |
| JOYTECH HEALTHCARE | China | 4 |
| COM BRIDGE | China | 4 |
| DONGGUAN CHINA EFFORT HEALTHCARE | China | 3 |
| WENZHOU KANGJU MEDICAL INSTRUMENT C | China | 3 |
| BUY NINGBO LT | China | 3 |
| DONGGUAN MINGFU | China | 3 |
| EVERFAITH SHANGHAI | China | 2 |
Share of Q1 2026 inbound shipments by source country
56 tier-2 + 4 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.